150 related articles for article (PubMed ID: 30045022)
1. Upregulation of RASSF1A in Colon Cancer by Suppression of Angiogenesis Signaling and Akt Activation.
Blanchard TG; Lapidus R; Banerjee V; Bafford AC; Czinn SJ; Ahmed H; Banerjee A
Cell Physiol Biochem; 2018; 48(3):1259-1273. PubMed ID: 30045022
[TBL] [Abstract][Full Text] [Related]
2. Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression.
Zakraoui O; Marcinkiewicz C; Aloui Z; Othman H; Grépin R; Haoues M; Essafi M; Srairi-Abid N; Gasmi A; Karoui H; Pagès G; Essafi-Benkhadir K
Mol Carcinog; 2017 Jan; 56(1):18-35. PubMed ID: 26824338
[TBL] [Abstract][Full Text] [Related]
3. Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth.
Ponnurangam S; Standing D; Rangarajan P; Subramaniam D
Mol Cancer Ther; 2013 May; 12(5):598-609. PubMed ID: 23427297
[TBL] [Abstract][Full Text] [Related]
4. Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells.
Banerjee A; Banerjee V; Czinn S; Blanchard T
Oncotarget; 2017 Apr; 8(16):26142-26153. PubMed ID: 28412728
[TBL] [Abstract][Full Text] [Related]
5. Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer.
Xing X; Gu X; Ma T; Ye H
Tumour Biol; 2015 Mar; 36(3):1773-80. PubMed ID: 25371074
[TBL] [Abstract][Full Text] [Related]
6. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
7. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic activity of a new andrographolide derivative in zebrafish and HUVECs.
Li J; Peng Y; Li S; Sun Y; Chan JY; Cui G; Wang D; Zhou GC; Lee SM
Eur J Pharmacol; 2016 Oct; 789():344-353. PubMed ID: 27471159
[TBL] [Abstract][Full Text] [Related]
9. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.
Miyazaki S; Kikuchi H; Iino I; Uehara T; Setoguchi T; Fujita T; Hiramatsu Y; Ohta M; Kamiya K; Kitagawa K; Kitagawa M; Baba S; Konno H
Int J Cancer; 2014 Jul; 135(2):295-307. PubMed ID: 24375080
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide inhibits osteopontin expression and breast tumor growth through down regulation of PI3 kinase/Akt signaling pathway.
Kumar S; Patil HS; Sharma P; Kumar D; Dasari S; Puranik VG; Thulasiram HV; Kundu GC
Curr Mol Med; 2012 Sep; 12(8):952-66. PubMed ID: 22804248
[TBL] [Abstract][Full Text] [Related]
11. Robustaflavone induces G0/G1 cell cycle arrest and apoptosis in human umbilical vein endothelial cells and exhibits anti-angiogenic effects in vivo.
Sim WK; Park JH; Kim KY; Chung IS
Sci Rep; 2020 Jul; 10(1):11070. PubMed ID: 32632123
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis.
Pagano E; Borrelli F; Orlando P; Romano B; Monti M; Morbidelli L; Aviello G; Imperatore R; Capasso R; Piscitelli F; Buono L; Di Marzo V; Izzo AA
Pharmacol Res; 2017 May; 119():227-236. PubMed ID: 28193521
[TBL] [Abstract][Full Text] [Related]
13. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.
Vaish V; Sanyal SN
Biomed Pharmacother; 2012 Jul; 66(5):354-67. PubMed ID: 22397759
[TBL] [Abstract][Full Text] [Related]
14. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
15. SRJ09, a promising anticancer drug lead: Elucidation of mechanisms of antiproliferative and apoptogenic effects and assessment of in vivo antitumor efficacy.
Wong CC; Lim SH; Sagineedu SR; Lajis NH; Stanslas J
Pharmacol Res; 2016 May; 107():66-78. PubMed ID: 26940565
[TBL] [Abstract][Full Text] [Related]
16. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
17. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
Ci X; Xing C; Zhang B; Zhang Z; Ni JJ; Zhou W; Dong JT
Mol Cancer; 2015 Apr; 14():91. PubMed ID: 25896712
[TBL] [Abstract][Full Text] [Related]
18. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway.
Wang WG; Chen SJ; He JS; Li JS; Zang XF
Tumour Biol; 2016 Jul; 37(7):8869-77. PubMed ID: 26750098
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]